AMSBIO Announces Expansion of Tissue Biorepository and Collection Services
News Apr 24, 2013
Whole blood, plasma, serum, PBMCs and cerebrospinal fluid samples are available from a wide variety of donors. In addition AMSBIO is now able to offer collection services of patient samples that meet the demographic and medical history requirements of specific research studies.
Drawing upon over 20 years of serving this market - AMSBIO has established one of the most comprehensive ranges of tissue products to advance personalised medicine by putting these valuable samples in the hands of leading researchers.
Samples are available isolated from hundreds of different source tissues including human normal and diseased tissues, and a variety of genetic model organisms including mouse, rat, primates and plant species. These specimens are provided ready-to-use enabling the immediate study of molecules of interest eliminating the need for time consuming in-house sample collection and preparation.
These tissue products further extend AMSBIO's extensive bank of clinical and veterinary specimens that form a unique range of specimens in formalin fixed paraffin embedded (FFPE) or snap frozen formats. This extensive library of samples includes genomic DNA preparations, tissue specific PCR-ready first strand cDNAs, universal cDNA and 96 well and 384 well cDNA panels. Total, universal RNA and micro and total protein lysates are also available.
All tissue products are produced using rigorous standard operating procedures and through ethical procurement to ensure only the highest quality materials.
Controlling mosquito-borne illnesses has historically been difficult. Scientists have turned to manipulating Wolbachia, a parasitic bacterium within mosquitoes, as a way to control the reproductive fitness of mosquito populations that transmit human disease. In a study, researchers identified a new mobile DNA element in Wolbachia, which may contribute to improved control strategies for mosquito vectors of disease.